foxo4-dri senolytic peptide human trial 2024 regulates endothelial cell senescence via the P53 signaling pathway CHK2-USP37 axis stabilizes FOXO4 to

CHK2 USP37 axis stabilizes FOXO4 to sustain senescence and evade apoptosis PNAS Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells eBioMedicine Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients' treatment npj Aging FOXO4 DRI alleviates age related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice Aging

SKU: 5200238991 · From webdevsolutions.tech